HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark R Burns Selected Research
Mark R Burns Research Topics
Disease
6
Neoplasms (Cancer)
01/2019 - 05/2006
5
Septic Shock (Toxic Shock Syndrome)
02/2007 - 04/2005
5
Critical Illness (Critically Ill)
02/2007 - 04/2005
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2009 - 05/2006
2
Shock
02/2007 - 04/2005
1
Glioma (Gliomas)
12/2021
1
Diffuse Intrinsic Pontine Glioma
12/2021
1
Brain Neoplasms (Brain Tumor)
12/2021
1
Autoimmune Diseases (Autoimmune Disease)
12/2020
1
Inflammation (Inflammations)
12/2020
1
Neuroblastoma
01/2019
1
Melanoma (Melanoma, Malignant)
04/2009
1
Skin Neoplasms (Skin Cancer)
04/2009
1
Endotoxemia
01/2009
1
Sepsis (Septicemia)
01/2006
1
Breast Neoplasms (Breast Cancer)
01/2002
Drug/Important Bio-Agent (IBA)
10
Polyamines
IBA
12/2021 - 05/2006
5
Lipopolysaccharides
IBA
02/2007 - 04/2005
3
Ornithine Decarboxylase (Decarboxylase, Ornithine)
IBA
01/2019 - 04/2009
2
Eflornithine (Ornidyl)
FDA Link
01/2019 - 03/2014
2
Spermidine
IBA
01/2019 - 01/2002
2
Endotoxins
IBA
12/2006 - 01/2006
2
Spermine
IBA
04/2005 - 01/2002
1
dipinacoline glutamate
IBA
12/2021
1
Enzymes
IBA
01/2019
1
Cations
IBA
01/2019
1
Pharmaceutical Preparations
IBA
01/2019
1
Heavy Chain Fusion Regulatory Protein 1
IBA
01/2019
1
Drug Combinations
IBA
04/2009
1
Nitrogen
IBA
04/2009
1
Sulfonamides
IBA
01/2009
1
Drinking Water
IBA
05/2006
1
MQT 1426
IBA
05/2006
1
Lysine (L-Lysine)
FDA Link
04/2005
Therapy/Procedure
4
Therapeutics
12/2021 - 05/2006
1
Drug Therapy (Chemotherapy)
01/2019
1
Neoadjuvant Therapy
03/2014